Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

by Kus T, Aktas G, Sevinc A, Kalender ME, Camci C
Published 2015-06-01

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer pa...

by Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S
Published 2016-04-01

Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel

by Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C
Published 2016-08-01

Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

by Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C
Published 2015-12-01

Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients

by Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C
Published 2016-09-01